63
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Tuberculosis Prevention in College Students

, MD, MPH, , MD, , MD & , MD
Pages 53-58 | Published online: 06 Aug 2010

  • Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR. 2000;49(RR-6):1-51. Available from: www.cdc.gov/nchstp/tb .
  • American College Health Association. ACHA Guidelines. Tuberculosis screening of college and university students. November 2000;1-3. Available from: www.acha.org/info_resources .
  • Cobelens FGJ, van Duetekom H, Draayer-Jansen IWE, et al. Risk of infection with Mycobacterium tuberculosis in travelers to areas of high tuberculosis endemicity. Lancet. 2000;356:461-465..
  • Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis. 2003;36:599-603..
  • Dye C, Scheele S, Dolin P, et al. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA. 1999;282:677-686..
  • Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR. 2003;52(RR-2):15-18..
  • World Health Organization. Reported estimates of BCG vaccine coverage. Available from: www.who.int/vaccines/globalsummary/timeseries/tscoveragebcg.htm .
  • International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid therapy for tuberculosis. Five years of follow-up in the IUAT trial. Bull WHO. 1982;60:555-564..
  • Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis. 1999;3:847-850..
  • Kim RB and the Editors of the Medical Letter. Handbook of Adverse Drug Interactions. New Rochelle, NY: The Medical Letter, Inc. 2003;469-473..
  • Centers for Disease Control and Prevention. Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection—United States, 2003. MMWR. 2003;52:735-739..
  • Nolan CM, Goldberg SV, Buskin SE. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. JAMA. 1999;281:1014-1018..
  • Baciewicz AM, Self TH. Isoniazid interactions. South Med J. 1985;78:714-718..

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.